Ambinter
Ambinter is a French chemical compound supplier and cheminformatics provider serving global pharmaceutical, cosmetic, food, and agrochemical drug-discovery buyers through a 46-million-compound catalog, a 126-billion virtual chemical space (AMBrosia), and custom synthesis services, operating as a brand of Greenpharma SAS.
- Company typePrivate
- Founded2011
- HeadquartersOrléans, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Ambinter does
Ambinter is a French chemical compound supplier and cheminformatics provider for early-stage drug discovery, operating as a brand of Greenpharma SAS since its acquisition on July 1, 2011. The company is headquartered at 3 allée du Titane, Orléans, and serves pharmaceutical, cosmetic, food, agrochemical, and chemical industry buyers worldwide, with academic research institutions as a secondary segment. Its commercial core is a catalog of over 46 million real compounds for high-throughput screening, building blocks, fragments, and natural products, supplemented by the AMBrosia ultra-large virtual chemical space — a partnership with BioSolveIT containing approximately 126 billion synthetically accessible drug-like compounds accessible via Chemical Space Docking and the infiniSee platform.
The technology stack combines the 46-million-compound catalog and the AMBrosia virtual space with an in-house analytical chemistry platform (NMR, LC/MS, HPLC, elemental analysis) for QC, cheminformatics and molecular modeling services (QSAR, docking, virtual screening, SAR analysis, customized library design, web-based database development), and a custom synthesis capability spanning milligrams to tens of grams with feasibility, cost, timeline, and purity guarantees. Distribution is primarily direct sales (email, mail, fax, website) with personalized follow-up by commercial staff backed by synthetic chemists and cheminformatics experts; the company also distributes Greenpharma compound libraries (natural compound, endogenous ligand, plant extract) and Prestwick Chemical drug libraries under channel agreements.
Revenue is generated across multiple streams: transactional brokerage of catalog compounds, one-time licensing of customized compound libraries, and project-based professional services for custom synthesis, medicinal chemistry, and molecular modeling. Pricing is in EUR or USD with CPT/DAP Incoterms 2020 delivery, a 200 EUR / 220 USD minimum order, 30-day payment terms on standard orders, 50% advance on orders of 3000 EUR or more, and possible 100% advance for new customers. Orders are quoted within two days; physical samples derived from virtual hits are delivered within weeks. The business has no disclosed funding, no public headcount, and operates as a non-independently-financed brand inside its parent CRO.
Ambinter firmographics
Firmographics- Name
- Ambinter
- Legal name
- GREENPHARMA SAS
- Website
- https://ambinter.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ambinter is a French chemical compound supplier and cheminformatics provider serving global pharmaceutical, cosmetic, food, and agrochemical drug-discovery buyers through a 46-million-compound catalog, a 126-billion virtual chemical space (AMBrosia), and custom synthesis services, operating as a brand of Greenpharma SAS.
- Ownership category
- akta.pro rank
Ambinter industry classification
Industry- Product category
- Research Chemicals Supply
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Scientific Research and Development Services (5417)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
- akta.pro secondary industry
- Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE)
Keywords
Where Ambinter is headquartered
LocationHeadquarters
- HQ city
- Orléans
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Ambinter business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations
Revenue model
- Chemical Compound Brokerage: Broker in chemical compounds with over 46 million references available for research chemical supply, serving pharmaceutical, cosmetic, food, and agrochemical industries.
- Customized Compound Libraries: Supply of customized compound libraries (targeted or diverse) for specific research needs, delivered to pharmaceutical and biotech customers.
- On-Demand Synthesis: Custom synthesis services ranging from milligrams to tens of grams scale, with feasibility evaluation, pricing, delivery time, and purity guarantees. Revenue generated per project with payment terms including 50% advance for orders >= 3000 EUR.
- Medicinal Chemistry Services: Medicinal chemistry support including compound optimization and SAR analysis for drug discovery projects.
- Molecular Modelling: Cheminformatics and molecular modeling services including QSAR, docking, virtual screening, and database development.
- Analytical Chemistry Services: Quality control services using NMR, LC/MS, HPLC, elemental analysis and other analytical techniques to support compound verification.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Standard orders |
| Hybrid | Multi-year contract | Large orders (>= 3000 EUR) |
| One time/ perpetual license | Pay-as-you-go | New customer orders |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Ambinter product offering
Product offeringCore offering
Ambinter supplies advanced research chemical compounds and related services for drug discovery applications. The company offers a database of over 46 million compounds for high-throughput screening, building blocks, fragments, and natural products, complemented by the AMBrosia Chemical Space platform (126 billion virtual compounds) and custom synthesis, cheminformatics, molecular modeling, and analytical chemistry services.
Product overview
Ambinter is a brand of Greenpharma SAS (acquired July 1, 2011) offering a unified platform of chemical compounds and related services for drug discovery. The core offering centers on a compound database of over 46 million compounds for high-throughput screening, supported by custom synthesis services and cheminformatics & molecular modeling capabilities. The product portfolio includes AMBrosia Chemical Space (a partnership with BioSolveIT featuring 126 billion virtual compounds) and Greenpharma Compound Libraries (Natural Compound Library, Human Endogenous Ligand Library, Plant Extract Library). The company also provides analytical chemistry services (NMR, LC/MS, HPLC, elemental analysis) and R&D project management.
Differentiator
Problem solved
Functional benefit
Brands
- AMBrosia: A chemical space platform in partnership with BioSolveIT, offering access to over 125 billion synthetically accessible drug-like compounds for drug discovery projects.
Products and services
- Compound Database (46 million compounds) A comprehensive searchable database containing over 46 million compounds for high-throughput screening, building blocks, fragments, and natural products, designed for pharmaceutical, biotech, cosmetic, food, and agrochemical researchers in drug discovery.
- AMBrosia Chemical Space
Quantifiable outcome
- 125,924,571,692 synthetically accessible drug-like compounds available through AMBrosia
- +2 more outcomes
Companies that use Ambinter
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles5 records
Ambinter technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature5 records
Ambinter partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Greenpharma SAScoreAmbinter was acquired and became a brand of Greenpharma SAS in July 2011. Greenpharma provides R&D solutions with core expertise in natural substances and a multidisciplinary technical platform. This partnership enables Ambinter to offer additional services including custom synthesis, chemoinformatics, molecular modeling, analytical chemistry, and R&D project management. Greenpharma's platform supports pharmaceutical, cosmetic, and food industry applications.
- BioSolveITcoreStrategic partnership to create AMBrosia, an ultra-large chemical space containing 125,924,571,692 synthetically accessible drug-like compounds. BioSolveIT provides the Chemical Space Docking technology and infiniSee platform for exploring the virtual compound space. Ambinter provides unique in-house building blocks and chemical reactions. Any molecule from AMBrosia can be ordered directly from Ambinter for synthesis and delivery.
- Prestwick ChemicalminorAmbinter features and distributes Prestwick Chemical libraries including the Prestwick Chemical Library (1760 FDA-approved drugs), Prestwick Phytochemical Library, Drug-Fragment Library, CNS Drug Library, GPCR Drug Library, Peptidic Macrocycle Library, Original Molecules Library, and C. Elegans Library.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Ambinter competitors and assessment
Company assessmentBroad incumbents
- Sigma-Aldrich (MilliporeSigma): Largest life science reagents and chemicals supplier; broad incumbent in research chemicals with overlapping catalog and custom synthesis capabilities, but serves as a one-stop-shop across many life science verticals beyond drug discovery.
- Prestwick Chemical: Supplier of curated FDA-approved and specialty drug libraries (including those distributed via Ambinter); comparable in pharma library offerings though Prestwick focuses on curated smaller-scale drug-focused sets rather than ultra-large catalogs.
Direct peers
- Combi-Blocks: Provider of chemical building blocks, screening libraries, and custom synthesis for medicinal chemistry and drug discovery, comparable to Ambinter in catalog and custom chemistry offerings.
- Life Chemicals: Supplier of screening libraries, building blocks, and custom synthesis for drug discovery; overlaps with Ambinter in pharma-facing compound catalog and on-demand synthesis services.
- Enamine: Ukraine-based supplier of building blocks, screening libraries, and custom synthesis services for drug discovery; closely comparable to Ambinter in catalog scope, custom synthesis offering, and target customer base of pharma/CRO researchers.
- Mcule: Online chemical marketplace and database with virtual compound screening capabilities; comparable to Ambinter in bridging catalog access with cheminformatics tools for drug discovery.
- ChemSpace: Online marketplace and supplier of building blocks, screening compounds, and custom chemistry with a strong e-commerce ordering motion; comparable to Ambinter in compound supply but with a more modern digital purchasing flow.
- MolPort: Chemical compound marketplace aggregating millions of compounds from global suppliers; directly comparable as a discovery chemistry sourcing platform serving pharma and biotech customers.
- eMolecules: Search engine and sourcing platform for chemical compounds used in drug discovery and research; comparable as a digital compound sourcing layer for pharma and biotech buyers.
Emerging players
- BioSolveIT: Cheminformatics software vendor (infiniSee, Chemical Space Docking) that co-developed AMBrosia with Ambinter; comparable as a complementary technology provider in virtual screening and ultra-large chemical space exploration rather than a direct catalog competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Ambinter social profiles
Digital presenceAmbinter financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ambinter leadership team
Management profileNumber of profiles
Ambinter funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ambinter M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ambinter
What does Ambinter do?
Ambinter supplies advanced research chemical compounds and related services for drug discovery applications. The company offers a database of over 46 million compounds for high-throughput screening, building blocks, fragments, and natural products, complemented by the AMBrosia Chemical Space platform (126 billion virtual compounds) and custom synthesis, cheminformatics, molecular modeling, and analytical chemistry services.
Is Ambinter a public or private company?
Ambinter is a private company. It is classified as corporate owned and is currently operating.
When was Ambinter founded?
Ambinter was founded in 2011. It employs 11 to 50 people.
Where is Ambinter based?
Ambinter is headquartered in Orléans, France, in the Europe region.
How does Ambinter make money?
Six revenue lines are on record. Chemical Compound Brokerage is the primary driver. The others are customized Compound Libraries, on-Demand Synthesis, medicinal Chemistry Services, molecular Modelling and analytical Chemistry Services.
Who are Ambinter's main competitors?
Broad incumbents on record are Sigma-Aldrich (MilliporeSigma) and Prestwick Chemical. Direct peers are Combi-Blocks, Life Chemicals, Enamine, Mcule, ChemSpace, MolPort and eMolecules. BioSolveIT is listed as an emerging player.
Does Ambinter have an API?
No public API is recorded for Ambinter.
What industry is Ambinter in?
Ambinter's product category is Research Chemicals Supply. Its primary akta.pro industry code is HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization, with a secondary code of HLAGAHAE, Chiral / Asymmetric Synthesis & Complex Chemistry Services. Its NAICS code is 32541 and its SIC code is 2833.